To the Editor, Platelets are blood elements which take part in the first phase of hemostasis. Etiology of thrombocytopenia depends on deficient proliferation, distribution disorder or excess degradation. Excess degradation appears as idiopathic thrombocytopenic purpura (ITP) and viral infections [1] . While CMV-related hematologic problems are frequently seen in newborns and immune-compromised patients, they are rare in normal subjects [2] . While patients who developed thrombocytopenia are reported in literature, numbers of pediatric cases are small [3] [4] [5] . In this paper, we presented three infant cases that were considered to have ITP in the initial assessment, who were detected to have CMV and responded to IVIG treatment. Case 1; An 11-months-old boy was admitted due to rash on the legs. The rash was started a day ago. Platelet count was 18.700/mm 3 . Peripheral blood smear examination was normal with regard to red blood cell (RBC) and WBC count; there were 1-2 platelets in every field, they were large and single. CMV IgM was found positive in viral panel. Because of typical findings of ITP, bone marrow aspiration was not performed [1] . Single dose of IVIG was administered in the dose of 1 g/kg. We did not administer the ganciclovir. The patient was discharged as platelet count was 229.000/mm 3 . Case 2; A 5 months old boy was admitted due to rash on the body and the legs. The rash was started a day ago. Platelet count was 14.700/mm 3 . Peripheral blood smear was consistent with ITP. CMV IgM was found positive. Bone marrow aspiration was not performed. Single dose of IVIG was administered. Ganciclovir treatment was not started. The patient was discharged as platelet count was 172.000/mm 3 . Case 3; A 2.5 months old girl was admitted due to rash on the arms. Her rash was started a day ago. She had the history of hospitalization in newborn intensive care unit due to meconium aspiration syndrome. Platelet counts of parents were within normal ranges. Platelet count was 9.314/mm 3 . Peripheral blood smear was consistent with ITP. CMV IgM was found positive. Bone marrow aspiration was not performed. Single dose of IVIG was administered. Ganciclovir treatment was not started. The patient was discharged as platelet count was 313.000/mm 3 . Platelet count was found as 69.000/mm 3 on her control 1 week after discharge and she was referred to Pediatric Hematology Department. Informed consent was obtained from the families of all three cases.
While acquired CMV infection may lead to severe clinical conditions like encephalitis, pneumonia, hepatitis and graft rejection in immune-compromised patients, it is usually asymptomatic in immune-competent individuals or goes with a nonspecific viral infection or mononucleosislike syndrome [2] . It has been reported in a small number of studies that CMV-related thrombocytopenia may present with severe refractory ITP and it is difficult to discriminate this from typical ITP in immune-competent children. They suggested that CMV infection should be examined before making a diagnosis of ITP [4, 5] . We also detected CMV in three patients with thrombocytopenia who diagnosed with ITP. In all of these studies, it was reported that the cases were refractory to IVIG treatment and were recovered by ganciclovir treatment. In contrast to these studies, we had complete response to IVIG treatment in our three cases; only in one patient thrombocytopenia was relapsed 1 week later. When we looked closely, we saw that in the cases of these studies had acute signs of infection (fever and/or raised transaminase) at the time of thrombocytopenia in contrast to our patients herein described (Table 1 ).
In conclusion, differentiation between acute CMV-related thrombocytopenia and CMV-related ITP secondary to a recent but not active CMV infection would be useful for making a treatment plan.
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